NYSE:LHHealthcare
How Labcorp’s Raised 2026 Outlook and Oncology Push Could Shape Labcorp Holdings (LH) Investors
In the first quarter of 2026, Labcorp Holdings Inc. reported revenue of US$3,537.6 million and net income of US$277.8 million, with basic earnings per share from continuing operations rising to US$3.37 year over year.
Alongside raising its full-year 2026 revenue outlook, Labcorp continued returning capital to shareholders through a long-running buyback program and expanded its oncology testing capabilities with nationwide access to an FDA-approved companion diagnostic for KEYTRUDA-based...